Laminil™ is a cutting-edge treatment developed for equine laminitis that utilizes the active ingredient cromolyn sodium, known for its mast cell stabilizing properties. This innovative product is designed to modulate the inflammatory response associated with this debilitating condition in horses. Laminil™ is available in two formats: a transdermal cream and a sterile solution, both administered under veterinary supervision.

The Laminil™ Cream, presented in a 120-gram jar, offers targeted prevention and treatment through daily applications that promote blood flow and hoof health. The Sterile Solution, packaged in 60mL vials, is ideal for limb perfusions or intramuscular injections.

With a focus on restoring vital functions and preventing further inflammatory episodes, Laminil™ has garnered positive testimonials from veterinarians and horse owners alike. It not only aids in recovery but also plays a preventative role against laminitis, making it an essential tool for equine health. Widely used across the United States, Canada, and the UAE, Laminil™ has established a reputation for safety and efficacy in the management of equine laminitis.